Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IE70
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016853 | isomerase activity | 2 | 10 |
GO:0016859 | cis-trans isomerase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 344 | 348 | PF00656 | 0.369 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.297 |
CLV_NRD_NRD_1 | 361 | 363 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 418 | 420 | PF00675 | 0.256 |
CLV_PCSK_FUR_1 | 416 | 420 | PF00082 | 0.194 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.265 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 360 | 362 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 394 | 396 | PF00082 | 0.301 |
CLV_PCSK_KEX2_1 | 418 | 420 | PF00082 | 0.256 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.253 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.555 |
CLV_PCSK_PC1ET2_1 | 394 | 396 | PF00082 | 0.301 |
CLV_PCSK_PC7_1 | 140 | 146 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 353 | 357 | PF00082 | 0.494 |
CLV_PCSK_SKI1_1 | 412 | 416 | PF00082 | 0.196 |
DEG_APCC_DBOX_1 | 394 | 402 | PF00400 | 0.306 |
DEG_SPOP_SBC_1 | 255 | 259 | PF00917 | 0.527 |
DEG_SPOP_SBC_1 | 264 | 268 | PF00917 | 0.539 |
DOC_CKS1_1 | 373 | 378 | PF01111 | 0.345 |
DOC_MAPK_gen_1 | 149 | 156 | PF00069 | 0.341 |
DOC_MAPK_gen_1 | 392 | 400 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 149 | 156 | PF00069 | 0.334 |
DOC_MAPK_MEF2A_6 | 362 | 371 | PF00069 | 0.407 |
DOC_MAPK_MEF2A_6 | 81 | 89 | PF00069 | 0.382 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.338 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.383 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.297 |
DOC_USP7_MATH_1 | 255 | 259 | PF00917 | 0.770 |
DOC_USP7_MATH_1 | 264 | 268 | PF00917 | 0.722 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.603 |
DOC_USP7_MATH_1 | 304 | 308 | PF00917 | 0.647 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.411 |
DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.740 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.561 |
DOC_WW_Pin1_4 | 369 | 374 | PF00397 | 0.475 |
LIG_Actin_WH2_2 | 403 | 420 | PF00022 | 0.306 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.484 |
LIG_BIR_III_4 | 294 | 298 | PF00653 | 0.569 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.529 |
LIG_CSL_BTD_1 | 373 | 376 | PF09270 | 0.337 |
LIG_eIF4E_1 | 312 | 318 | PF01652 | 0.392 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.354 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.479 |
LIG_FHA_1 | 272 | 278 | PF00498 | 0.615 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.500 |
LIG_FHA_2 | 258 | 264 | PF00498 | 0.780 |
LIG_FHA_2 | 373 | 379 | PF00498 | 0.470 |
LIG_FHA_2 | 403 | 409 | PF00498 | 0.266 |
LIG_Integrin_RGD_1 | 395 | 397 | PF01839 | 0.306 |
LIG_LIR_Apic_2 | 58 | 63 | PF02991 | 0.339 |
LIG_LIR_Gen_1 | 384 | 391 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 311 | 315 | PF02991 | 0.526 |
LIG_LYPXL_yS_3 | 84 | 87 | PF13949 | 0.369 |
LIG_SH2_CRK | 312 | 316 | PF00017 | 0.404 |
LIG_SH2_SRC | 312 | 315 | PF00017 | 0.413 |
LIG_SH2_STAP1 | 169 | 173 | PF00017 | 0.475 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 354 | 357 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 386 | 389 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.296 |
LIG_SH3_1 | 145 | 151 | PF00018 | 0.306 |
LIG_SH3_1 | 361 | 367 | PF00018 | 0.355 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.306 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.663 |
LIG_SH3_3 | 324 | 330 | PF00018 | 0.412 |
LIG_SH3_3 | 361 | 367 | PF00018 | 0.419 |
LIG_SH3_3 | 370 | 376 | PF00018 | 0.333 |
LIG_SH3_3 | 419 | 425 | PF00018 | 0.255 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.396 |
LIG_SH3_3 | 79 | 85 | PF00018 | 0.322 |
LIG_SH3_5 | 101 | 105 | PF00018 | 0.256 |
LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.297 |
LIG_SUMO_SIM_par_1 | 152 | 158 | PF11976 | 0.388 |
LIG_TRAF2_1 | 375 | 378 | PF00917 | 0.458 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.382 |
LIG_UBA3_1 | 317 | 325 | PF00899 | 0.369 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.473 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.282 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.458 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.730 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.569 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.523 |
MOD_CK1_1 | 372 | 378 | PF00069 | 0.414 |
MOD_CK2_1 | 257 | 263 | PF00069 | 0.638 |
MOD_CK2_1 | 296 | 302 | PF00069 | 0.647 |
MOD_CK2_1 | 372 | 378 | PF00069 | 0.358 |
MOD_Cter_Amidation | 142 | 145 | PF01082 | 0.332 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.490 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.602 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.564 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.474 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.505 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.683 |
MOD_GlcNHglycan | 267 | 270 | PF01048 | 0.643 |
MOD_GlcNHglycan | 306 | 309 | PF01048 | 0.682 |
MOD_GlcNHglycan | 388 | 392 | PF01048 | 0.306 |
MOD_GlcNHglycan | 421 | 425 | PF01048 | 0.442 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.679 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.581 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.525 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.774 |
MOD_GSK3_1 | 289 | 296 | PF00069 | 0.637 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.258 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.342 |
MOD_PIKK_1 | 425 | 431 | PF00454 | 0.388 |
MOD_PK_1 | 55 | 61 | PF00069 | 0.393 |
MOD_PKA_2 | 255 | 261 | PF00069 | 0.519 |
MOD_Plk_2-3 | 402 | 408 | PF00069 | 0.266 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.388 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.694 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.476 |
MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.735 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.561 |
MOD_ProDKin_1 | 369 | 375 | PF00069 | 0.476 |
TRG_DiLeu_BaEn_2 | 123 | 129 | PF01217 | 0.297 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.409 |
TRG_ENDOCYTIC_2 | 386 | 389 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.513 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 360 | 362 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 415 | 418 | PF00400 | 0.300 |
TRG_NLS_MonoCore_2 | 391 | 396 | PF00514 | 0.306 |
TRG_NLS_MonoExtC_3 | 391 | 397 | PF00514 | 0.388 |
TRG_Pf-PMV_PEXEL_1 | 180 | 184 | PF00026 | 0.586 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HSF6 | Leptomonas seymouri | 61% | 100% |
A0A0S4J8C1 | Bodo saltans | 35% | 100% |
A0A3R7K0E7 | Trypanosoma rangeli | 43% | 100% |
A4HC99 | Leishmania braziliensis | 78% | 100% |
C9ZRL7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9AVN6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4QBU3 | Leishmania major | 93% | 100% |
V5BR42 | Trypanosoma cruzi | 42% | 100% |